Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
453 studies found for:    H19
Show Display Options
Rank Status Study
1 Completed Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Biological: BC-819
2 Completed
Has Results
Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Biological: DTA-H19
3 Completed Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer
Condition: Bladder Neoplasms
Intervention: Drug: DTA-H19
4 Active, not recruiting
Has Results
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Condition: Superficial Bladder Cancer
Intervention: Biological: BC-819/PEI
5 Completed Identification and Characterization of the Methylation Abnormalities on Whole Genome Among Infertile Men
Condition: Oligospermia
Intervention: Other: methylation analyses on spermatozoa from infertile men
6 Active, not recruiting Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma
Condition: Pancreas, Adenocarcinoma
Intervention: Biological: Biological/Vaccine: BC-819
7 Unknown  1H-19F Gastrointestinal MRI in Health and IBS
Condition: Irritable Bowel Syndrome
Interventions: Device: 19F capsule;   Dietary Supplement: sterculia
8 Recruiting Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans
Conditions: Assisted Reproductive Technology;   Freezing/Thawing Procedure;   Prolonged Culture Procedure
Interventions: Other: Sample of cord blood;   Other: Sample of placenta
9 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
10 Completed P. Gingivalis IgG Titer Test for Periodontitis
Condition: Periodontitis
11 Unknown  The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships
Conditions: Peptic Ulcer With H. Pylori Infection;   Gastritis With H. Pylori Infection
Intervention: Drug: Rabeprazole vs. Esomeprazole
12 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
13 Completed
Has Results
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
Condition: Influenza
Interventions: Biological: GSK Biologicals' FluLaval®;   Biological: Placebo (saline);   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A;   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A
14 Completed
Has Results
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults
Conditions: Influenza A Virus, H1N1 Subtype;   Influenza Infection
Interventions: Biological: GSK2340274A;   Biological: GSK2340273A;   Biological: Seasonal trivalent influenza vaccine (TIV);   Biological: Saline placebo
15 Completed Drug Interaction Between CKD-501 and Metformin
Condition: Healthy Male Volunteers
Interventions: Drug: Metformin;   Drug: CKD-501
16 Completed
Has Results
Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density
Condition: Osteoporosis
Interventions: Drug: Placebo;   Drug: DP001
17 Completed
Has Results
COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine
Condition: Pneumonia & AOM Caused by S. Pneumoniae & H. Influenzae
Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A;   Biological: Havrix;   Biological: Engerix-B;   Biological: Infanrix hexa;   Biological: GSK Biologicals' DTPa-IPV/Hib vaccine
18 Completed
Has Results
Safety Study to Evaluate FluMist in Immunocompromised Children
Condition: Cancer
Interventions: Biological: FluMist;   Biological: Placebo
19 Completed Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori
Condition: H. Pylori Infection
Interventions: Drug: Sequential therapy for 14 days;   Drug: Sequential therapy for 10 days;   Drug: Triple therapy for 14 days
20 Completed
Has Results
Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.
Condition: Infections, Streptococcal
Interventions: Biological: Pneumococcal vaccine GSK1024850A;   Biological: Tritanrix-HepB/Hib;   Biological: measles;   Biological: Rotarix;   Biological: Local OPV

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years